Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aef54c233bb892661418586b260708e6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
filingDate |
2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e818ae883df78266032ac158c1913af7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9e9701cdac74a3d66c4915e715b233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe0d86783c114286e3ad0dda4ca513d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7424b76a8a50c77a35ec4862815b446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e391b2d2be2430e9f080f67064b0f53c |
publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021205130-A1 |
titleOfInvention |
Porous structures for extended release drug delivery devices |
abstract |
A therapeutic device for extended release drug delivery including a refillable reservoir configured to receive a therapeutic agent and having an outlet for delivery of the therapeutic agent to a patient from the reservoir over an extended period. A porous structure is coupled near the outlet of the reservoir, the porous structure formed of sintered material. A barrier layer is coupled to the reservoir on or adjacent a surface of the porous structure such that the therapeutic agent passes through both the porous structure and the barrier layer upon delivery from the reservoir through the outlet. The porous structure is tuned to deliver the therapeutic agent at a diffusion rate and the barrier layer is adapted to block passage of particles having an average particle size within an average particle size range that is outside an average particle size range blocked by the porous structure. Related methods and systems are provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617680-B2 |
priorityDate |
2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |